ExSight Ventures
9
25M
6
1.50
1
0.33
1
- Stages of investment
- Areas of investment
Summary
ExSight Ventures appeared to be the VC, which was created in 2014. The main office of represented VC is situated in the New York. The venture was found in North America in United States.
The fund has exact preference in some founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Genetics, Biotechnology. Among the various public portfolio startups of the fund, we may underline ONL Therapeutics, RetroSense Therapeutics, lensgen Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.
The high activity for fund was in 2017. Despite it in 2019 the fund had an activity. Comparing to the other companies, this ExSight Ventures performs on 9 percentage points less the average number of lead investments. The higher amount of exits for fund were in 2016. The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars.
The typical case for the fund is to invest in rounds with 5 participants. Despite the ExSight Ventures, startups are often financed by National Institutes of Health, MedTech Innovator, Tech Coast Angels. The meaningful sponsors for the fund in investment in the same round are InFocus Capital Partners, Hatteras Venture Partners, Aju IB Investment. In the next rounds fund is usually obtained by InFocus Capital Partners, HOYA Group, Invest Michigan.
We also calculated 5 valuable employees in our database.
Investments analytics
Analytics
- Total investments
- 9
- Lead investments
- 1
- Exits
- 1
- Rounds per year
- 1.50
- Follow on index
- 0.33
- Investments by industry
- Therapeutics (8)
- Biotechnology (7)
- Health Care (4)
- Pharmaceutical (2)
- Medical (2) Show 4 more
- Investments by region
-
- United States (8)
- United Kingdom (1)
- Peak activity year
- 2020
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 11M
- Group Appearance index
- 1.00
- Avg. company exit year
- 7
- Avg. multiplicator
- 3.53
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| DTx Pharma | 06 Jan 2020 | Biotechnology, Therapeutics | Early Stage Venture | 10M | United States, California, San Diego |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.